Tyers Asset Management’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$1M Hold
7,056
0.03% 327
2019
Q2
$883K Hold
7,056
0.03% 356
2019
Q1
$778K Hold
7,056
0.03% 361
2018
Q4
$692K Buy
7,056
+208
+3% +$22.6K 0.03% 334
2018
Q3
$846K Buy
6,848
+1,280
+23% +$144K 0.03% 333
2018
Q2
$553K Hold
5,568
0.02% 409
2018
Q1
$492K Hold
5,568
0.02% 421
2017
Q4
$549K Buy
5,568
+864
+18% +$84.7K 0.02% 416
2017
Q3
$453K Buy
4,704
+656
+16% +$59.4K 0.02% 430
2017
Q2
$383K Buy
4,048
+1,584
+64% +$146K 0.01% 477
2017
Q1
$201K Buy
2,464
+368
+18% +$30.8K 0.01% 539
2016
Q4
$178K Buy
+2,096
New +$165K 0.01% 518

Other funds holding WST

Tyers Asset Management's WST Position: Q3 2019 in Review

Tyers Asset Management held its West Pharmaceutical (WST) position steady in Q3 2019 at 7,056 shares worth $1M. The position accounts for 0.03% of the portfolio, ranked #327.

Tyers Asset Management first reported a position in WST in Q4 2016 and has held it in 12 quarters since. 406 funds tracked by Wall St. Rank hold WST as of Q3 2019.

  • Tyers Asset Management held 7,056 shares of West Pharmaceutical worth $1M as of Q3 2019.
  • Tyers Asset Management left its West Pharmaceutical share count unchanged in Q3 2019.
  • West Pharmaceutical made up 0.03% of Tyers Asset Management's portfolio in Q3 2019, its #327 holding.
  • Tyers Asset Management first reported a position in West Pharmaceutical in Q4 2016 and has held it in 12 quarters since.
  • 406 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2019.

Based on Tyers Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.